The RPL11 gene helps your cells build ribosomes, the structures they use to make proteins needed for growth and repair. This gene plays an important role in normal blood cell production, so if it does not work well, the bone marrow may struggle to make enough red blood cells. Certain variants in the RPL11 gene can cause Diamond-Blackfan anemia, which often leads to anemia and may also affect growth or cause some physical differences.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the code for proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes take place, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
RPL11Gene function
What if the gene works
The RPL11 gene helps build ribosomes, the cell parts that make proteins. It also helps cells sense stress and slow growth when protein-making machinery is disrupted.
Risk
What if the gene does not work
Variants in the RPL11 gene most often cause Diamond-Blackfan anemia, with too few red blood cells. Some people also have growth differences or differences present from birth. Milder and more severe variants can influence when symptoms start and how marked they are.
Treatment
What does that mean for your treatment
No RPL11-specific treatment or drug choice is currently established. Care for people with pathogenic variants in the RPL11 gene follows standard management for Diamond-Blackfan anemia, and RPL11 is mainly being studied as part of broader ribosome-related treatment research rather than as a direct drug target.
Conditions associated with RPL11
Gene function
What if the gene works
Your cells need the RPL11 gene to keep protein production running smoothly. It helps build a working ribosome, the cell structure that turns genetic instructions into proteins. This explains how the RPL11 gene helps your cells make proteins for growth, repair, and everyday upkeep.
RPL11 helps assemble the large half of the ribosome. It works closely with 5S rRNA, a ribosome RNA piece, to place key parts where they belong.
As part of the ribosome, RPL11 helps the cell join amino acids into a protein chain. This lets genetic instructions be turned into the proteins your body uses every day.
RPL11 helps the ribosome keep its proper shape while it works. A steady ribosome can carry out protein production in a controlled, reliable way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some variants in the RPL11 gene reduce how much RPL11 protein a cell makes, while others change its shape enough to keep it from joining the ribosome, the cell’s protein making structure. This is how RPL11 gene variants affect ribosome function in Diamond-Blackfan anemia: protein production becomes less efficient and cells come under stress. Milder variants may leave some activity intact, while more disruptive variants often have a larger effect and can be linked to earlier or more marked features.
How variants are linked to conditions
Pathogenic variants in the RPL11 gene can cause Diamond-Blackfan anemia, an inherited condition that often appears in infancy with low red blood cell counts, tiredness, and sometimes birth differences such as changes in the thumbs, heart, or face. In families affected by RPL11 gene variants linked to Diamond-Blackfan anemia, the severity can vary widely, even between relatives. Some people mainly have anemia, while others have milder blood changes or more noticeable physical differences.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and are simply part of natural human variation. For many genes, carrying a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can by itself be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RPL11 gene. Risk usually depends most on the exact genetic change and family history, and people with concerns about their personal risk can speak with a doctor or genetic counselor.
Inheritance of RPL11 variants
RPL11-related conditions are usually inherited in an autosomal dominant pattern. This means a parent with a disease-causing variant in the RPL11 gene can pass it to a child, with a 50% chance in each pregnancy. Some cases happen because of a new, de novo variant, so the change is not inherited from either parent. For families asking how RPL11 variants are inherited, both sons and daughters can inherit and pass on the variant.
What does my RPL11 result mean for my family?
A harmful change in the RPL11 gene is usually passed down in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same change and may want to learn their own status. In some families, several people have related features, while in others the signs can be mild or look different from one person to another. Some RPL11 changes happen for the first time in one person, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
Genetic testing of the RPL11 gene for Diamond-Blackfan anemia usually uses a blood or saliva sample. A lab reads the DNA sequence and looks for variants in the RPL11 gene, and results can show whether a pathogenic variant is present, absent, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the RPL11 gene may be worth considering when a child or adult has a rare inherited anemia that starts early in life, especially if it comes with slow growth, thumb or arm differences, or similar findings in relatives. Finding an RPL11 change can help confirm the cause and clarify whether it may run in the family.
A genetic result is only one part of your health story
A genetic test result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may also help put a person’s individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This happens because inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target. As a result, the same treatment may work better for some people, have less effect in others, or make some people more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It explores links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the RPL11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, a new prescription, or how your medicines fit with your overall health, talk with your doctor or pharmacist.
History
RPL11 entered medical genetics through research on Diamond Blackfan anemia, a rare inherited condition that affects red blood cell production. In the 2000s, scientists began identifying ribosomal protein genes linked to this condition, and the RPL11 gene was recognized as one of them. From these first observations, research expanded steadily. Its discovery helped shift thinking about Diamond Blackfan anemia from a condition defined mainly by symptoms to one understood through specific inherited gene changes. Later studies also connected changes involving RPL11 to a broader picture of bone marrow failure and related syndromes. These findings made RPL11 part of an important chapter in the history of ribosome related diseases.